HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V Silingardi Selected Research

V Silingardi Research Topics

Disease

2Breast Neoplasms (Breast Cancer)
09/2002 - 05/2000
2Lymphoma (Lymphomas)
11/2000 - 03/2000
1Varicocele
08/2005
1Carcinoma (Carcinomatosis)
09/2002
1Disease Progression
05/2000
1Circulating Neoplastic Cells
05/2000
1Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2000
1Myocardial Infarction
03/2000
1Neoplasms (Cancer)
02/2000
1Diarrhea
01/2000
1Colorectal Neoplasms (Colorectal Cancer)
01/2000

Drug/Important Bio-Agent (IBA)

1Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2005
1Dacarbazine (DIC)FDA LinkGeneric
09/2002
1Nonsense Codon (Nonsense Mutation)IBA
09/2002
1PlasticsIBA
11/2000
1ImmunosorbentsIBA
11/2000
1EnzymesIBA
11/2000
1Protease Inhibitors (Protease Inhibitor)IBA
05/2000
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2000
1Messenger RNA (mRNA)IBA
05/2000
1SERPIN-B5 (maspin)IBA
05/2000
1SerpinsIBA
05/2000
1Proteins (Proteins, Gene)FDA Link
05/2000
1Pharmaceutical PreparationsIBA
03/2000
1Progesterone Receptors (Progesterone Receptor)IBA
02/2000
1Estrogens (Estrogen)FDA Link
02/2000
1Loperamide (Imodium)FDA LinkGeneric
01/2000
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2000
1Octreotide (Sandostatin)FDA LinkGeneric
01/2000

Therapy/Procedure

4Drug Therapy (Chemotherapy)
11/2000 - 01/2000
2Therapeutics
05/2000 - 03/2000
1PROMACE-CytaBOM protocol
03/2000